These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 18023104)
1. DNA methyltransferase 3B promoter polymorphism and its susceptibility to primary hepatocellular carcinoma in the Chinese Han nationality population: a case-control study. Wu Y; Lin JS World J Gastroenterol; 2007 Dec; 13(45):6082-6. PubMed ID: 18023104 [TBL] [Abstract][Full Text] [Related]
2. [Correlation between polymorphism in the promoter of DNA methyltransferase-3B and the risk of colorectal cancer]. Bao Q; He BS; Chen LP; Gu L; Nie ZL; Wang SK Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jan; 46(1):53-7. PubMed ID: 22490141 [TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphism in DNA methyltransferase 3B promoter and its association with gastric cardiac adenocarcinoma in North China. Wang YM; Wang R; Wen DG; Li Y; Guo W; Wang N; Wei LZ; He YT; Chen ZF; Zhang XF; Zhang JH World J Gastroenterol; 2005 Jun; 11(23):3623-7. PubMed ID: 15962389 [TBL] [Abstract][Full Text] [Related]
4. Association study of single nucleotide polymorphisms in XRCC1 gene with risk of hepatocellular carcinoma in Chinese Han population. Bi J; Zhong C; Li K; Chu H; Wang B Biomed Res Int; 2013; 2013():138785. PubMed ID: 23984316 [TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population. Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; El Kihal L; Hassar M; Akil A; Pineau P; Benjelloun S Infect Genet Evol; 2009 Sep; 9(5):877-81. PubMed ID: 19465161 [TBL] [Abstract][Full Text] [Related]
6. DNMT3B promoter polymorphism and risk of gastric cancer. Hu J; Fan H; Liu D; Zhang S; Zhang F; Xu H Dig Dis Sci; 2010 Apr; 55(4):1011-6. PubMed ID: 19517237 [TBL] [Abstract][Full Text] [Related]
7. Single nucleotide polymorphism in DNMT3B promoter and the risk for idiopathic thrombocytopenic purpura in Chinese population. Chen Z; Zhou Z; Chen X; Xu J; Liu A; Du W; Gu D; Ge J; Guo Z; Wang X; Dong X; Ren Q; Yang R J Clin Immunol; 2008 Sep; 28(5):399-404. PubMed ID: 18437543 [TBL] [Abstract][Full Text] [Related]
8. Promoter polymorphisms of DNMT3B and the risk of colorectal cancer in Chinese: a case-control study. Fan H; Zhang F; Hu J; Liu D; Zhao Z J Exp Clin Cancer Res; 2008 Jul; 27(1):24. PubMed ID: 18662374 [TBL] [Abstract][Full Text] [Related]
9. DNMT3B 579 G>T promoter polymorphism and risk of esophagus carcinoma in Chinese. Fan H; Liu DS; Zhang SH; Hu JB; Zhang F; Zhao ZJ World J Gastroenterol; 2008 Apr; 14(14):2230-4. PubMed ID: 18407600 [TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population. Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522 [TBL] [Abstract][Full Text] [Related]
11. A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Li XD; Li ZG; Song XX; Liu CF Pathology; 2010 Dec; 42(7):669-73. PubMed ID: 21080878 [TBL] [Abstract][Full Text] [Related]
12. DNA methyltransferase 3B -149C/T polymorphism and the risk of laryngeal squamous cell carcinoma: a case-control study. Zhang XM; Li S; Zhang QM Genet Mol Res; 2015 Oct; 14(4):12866-71. PubMed ID: 26505438 [TBL] [Abstract][Full Text] [Related]
13. Association of Functional Genetic Variants of HOTAIR with Hepatocellular Carcinoma (HCC) Susceptibility in a Chinese Population. Li H; Tang XM; Liu Y; Li W; Chen Q; Pan Y Cell Physiol Biochem; 2017; 44(2):447-454. PubMed ID: 29141248 [TBL] [Abstract][Full Text] [Related]
14. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population. Akkiz H; Sümbül AT; Bayram S; Bekar A; Akgöllü E Cancer Epidemiol; 2010 Aug; 34(4):448-52. PubMed ID: 20447891 [TBL] [Abstract][Full Text] [Related]
15. [Relationship between genetic polymorphism of promoter region let-7 and genetic susceptibility to hepatocellular carcinoma]. Huang F; Hu LM; Liu JB; Zhang YX; Hu ZB Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Dec; 45(12):1093-8. PubMed ID: 22336344 [TBL] [Abstract][Full Text] [Related]
16. Association of IL-2 polymorphisms and IL-2 serum levels with susceptibility to HBV-related hepatocellular carcinoma in a Chinese Zhuang population. Peng Q; Li H; Lao X; Deng Y; Chen Z; Qin X; Li S Infect Genet Evol; 2014 Oct; 27():375-81. PubMed ID: 25173083 [TBL] [Abstract][Full Text] [Related]
17. Association of CD44 polymorphisms and susceptibility to HBV-related hepatocellular carcinoma in the Chinese population. Deng Y; Chen ZJ; Lan F; He QT; Chen SY; Du YF; Li S; Qin X J Clin Lab Anal; 2019 Oct; 33(8):e22977. PubMed ID: 31301090 [TBL] [Abstract][Full Text] [Related]
18. Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population. Xie Q; Chen Z; Xia L; Zhao Q; Yu H; Yang Z Gene; 2018 Oct; 674():188-194. PubMed ID: 29940275 [TBL] [Abstract][Full Text] [Related]
19. The -250G/A and -514C/T Polymorphisms in Hepatic Lipase Gene Promoter Confers an Increased Risk of Hepatocellular Carcinoma in a Chinese Population. Niu CZ; Zhang FH; Li Y; Liu JJ; Bao CX Ann Hepatol; 2018 Oct; 17(6):992-1000. PubMed ID: 30600300 [TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of C-reactive protein increase susceptibility to HBV-related hepatocellular carcinoma in a Guangxi male population. Lao X; Ren S; Lu Y; Yang D; Qin X; Li S Int J Clin Exp Pathol; 2015; 8(12):16055-63. PubMed ID: 26884882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]